Compounded Semaglutide vs Ozempic: What’s the Difference and Which Is Safer?

Compounded semaglutide is a custom-mixed version of the same active ingredient found in the FDA-approved diabetes drug Ozempic, but it is not reviewed or approved by the FDA, and its quality can vary by pharmacy. Ozempic’s safety, dosing, and efficacy are backed by large clinical trials and strict manufacturing controls, while compounded products rely on the individual 503A pharmacy’s processes and testing. For most people, Ozempic (or another FDA-approved GLP-1) is preferred when it is available and affordable; compounded semaglutide should be reserved for situations when the brand drug is in shortage and a patient’s prescriber determines no approved alternative meets their medical need.

• Ozempic is FDA-approved to improve blood sugar and reduce cardiovascular risk in adults with type 2 diabetes, with doses of 0.5 mg, 1 mg, and 2 mg once weekly. (dailymed.nlm.nih.gov)
• Compounded semaglutide is not FDA-approved and may use either semaglutide base or semaglutide sodium salt, which is not studied in humans. (fda.gov)
• The FDA lists semaglutide on its drug shortage list, which allows 503A pharmacies to compound it only when Ozempic or Wegovy is unavailable. (fda.gov)
• Novo Nordisk reports Ozempic’s current list price is about $960 for a 4-week pen pack, with a planned reduction to $675 in January 2027. (novonordisk-us.com)
• Rx.com’s weight-loss program offers compounded semaglutide from $99 per month, including the online visit, when a provider determines it is appropriate.
• Seek medical care right away if you develop severe stomach pain, vision changes, or signs of low blood sugar while using any semaglutide product.

What Compounded Semaglutide and Ozempic Are

Definition first: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps the pancreas release insulin, slows stomach emptying, and lowers appetite. Ozempic is Novo Nordisk’s branded, FDA-approved injectable semaglutide. Compounded semaglutide is the same active molecule prepared by a 503A compounding pharmacy in a vial or prefilled syringe when commercial products are in shortage.

FDA approval matters: Every Ozempic pen you buy must match the specifications in its FDA license. A compounded vial does not go through the same pre-market review; instead, each pharmacy follows USP <797> standards and any state rules, and the prescriber assumes responsibility for its use.

For weight-loss indications, the dose needed is higher (up to 2.4 mg in Wegovy); prescribers sometimes use ozempic “off-label” or a compounded product to reach similar doses when Wegovy is out of stock. The off-label pathway is legal but should be clearly discussed with the patient.

How Semaglutide Works for Blood Sugar and Weight

Semaglutide mimics the gut hormone GLP-1, which increases insulin release only when blood sugar is high, suppresses glucagon, and slows gastric emptying, leading to earlier satiety and fewer calories consumed. Brain imaging studies also show reduced activity in reward centers, which may tame “food noise.” (pmc.ncbi.nlm.nih.gov)

In the STEP 1 trial, 2.4 mg weekly semaglutide led to a mean 14.9% weight loss over 68 weeks versus 2.4% with lifestyle changes alone. (nejm.org) The same mechanism applies to lower doses in Ozempic, though the primary FDA-labeled use is glucose control.

Regulatory Status and Quality Standards

Ozempic: Approved by the FDA in 2017 after multiple phase 3 SUSTAIN trials, with ongoing post-marketing surveillance. Manufacturing plants are inspected regularly, and every lot must meet stringent potency and sterility specifications. (dailymed.nlm.nih.gov)

Compounded semaglutide: Allowed only under Section 503A of the FD&C Act when the drug is on the FDA shortage list and made for an individually identified patient. The FDA has issued safety alerts about dosing errors and potency failures with compounded semaglutide. (fda.gov)

Salt vs base confusion: Some pharmacies compound semaglutide sodium, a raw ingredient intended for research, which has never been proven safe in humans. The FDA warns that misusing the salt form could cause dosing errors. (fda.gov)

Formulation, Potency, and Purity Differences

Ozempic is supplied in disposable multi-dose pens containing semaglutide base dissolved in water with disodium phosphate dihydrate, propylene glycol, and phenol as preservatives. Each pen is designed to deliver exact 0.25, 0.5, 1, or 2 mg doses.

Compounded products vary. Common variables include:

• Active ingredient: semaglutide base vs semaglutide sodium.
• Concentration: 1 mg/mL up to 5 mg/mL, which requires patients to draw tiny volumes into an insulin syringe-an error-prone process the FDA specifically warns against. (fda.gov)
• Stability testing: Many small pharmacies lack validated 90-day stability data, so beyond-use dates (BUD) can be conservative (e.g., 28 days refrigerated) or, worse, overly optimistic without evidence.
• Preservatives: Some compounders add benzyl alcohol, which is not present in Ozempic and may irritate tissue in repeated subcutaneous injections.

Cost Comparison and Insurance Coverage

Because Ozempic is a brand-name drug, retail cash prices hover around $900–$1000 per month. Novo Nordisk announced a list-price drop to $675 effective January 1, 2027, but that does not change today’s out-of-pocket cost unless a coupon or insurance benefit applies. (novonordisk-us.com) Commercial insurance may cover Ozempic for type 2 diabetes but rarely for weight loss unless other criteria are met.

When coverage is denied-or during ongoing national shortages-patients look to compounded semaglutide. Pricing depends on the pharmacy, but online ads range from $99 to $400 per month.

Rx.com transparency: Our Rx.com weight loss program offers compounded semaglutide from $99 per month (12-month plan) including the virtual visit, the medication at every dose, and shipping to your door, with nothing charged if the provider does not approve treatment.

Who Might Consider Each Option

Choose Ozempic when: You have type 2 diabetes and insurance covers the prescription, or you have cardiovascular or kidney disease benefits listed on the label. The clinical evidence is strongest here.

Consider compounded semaglutide when: 1) Ozempic or Wegovy is unavailable due to shortage, 2) your prescriber documents that no FDA-approved alternative can meet your medical need, and 3) you are willing to accept additional risks. A reputable pharmacy must supply a Certificate of Analysis (CoA) confirming potency and sterility.

How to Get Semaglutide Safely Online or Locally

Whether you choose a brand or compounded product, safety steps are non-negotiable:

Verify the source: Only fill prescriptions at state-licensed pharmacies. For compounded semaglutide, confirm the pharmacy is compliant with USP <797> and can provide batch testing documents.

Work with qualified providers: Platforms like Rx.com connect you with U.S.-licensed physicians who screen for contraindications such as medullary thyroid carcinoma or multiple endocrine neoplasia 2.

Compare prices in advance: Use the Rx.com discount card to see local cash prices for Ozempic and other GLP-1s, or explore our 503A price list article for compound cost ranges.

Follow titration guidance: Escalate doses slowly to reduce nausea. See our GLP-1 titration guide for a week-by-week schedule.